OClawVPS.com
Civilization Ventures
Edit

Civilization Ventures

https://www.civilizationventures.com
Last activity: 10.12.2025
Active
Invests in categories: HealthTechPlatformTechnologyCareBioTechHumanMedtechDataProductDiagnostics
Civilization Ventures is a VC firm focused on deep tech innovations in digital health and synthetic biology, founded by Shahram Seyedin-Noor.
News
76
Portfolio
58
Mentions
16
Investment Stage: Series A

Portfolio 58

DateNameWebsiteTotal RaisedLocation
10.12.2025Trial Libr...triallibrary.com$15MUnited Sta...
30.10.2025Curve Bios...curvebio.com$40MUnited Sta...
27.04.2023Foresight ...foresight-dx.com$132.75MUnited Sta...
06.04.2023Sensible B...sensible.bio$4.2MUnited Kin...
08.02.2023Evonetixevonetix.com$66.6MUnited Kin...
02.09.2022FidoCurefidocure.com-United Sta...
02.09.2022Babyscript...babyscripts.com$25.2MUnited Sta...
02.09.2022ClinOneclinone.com$8.6MUnited Sta...
02.09.2022TenSixtytensixty.bio--
02.09.2022Klivoklivo.com-Brazil, Sã...
Show more

News 76

DateTitleDescription
14.11.2019EVENT December 5th: PhD to Founder: What to Know Before Starting Your Life Science CompanyAt Civilization VC, we believe PhD scientists are uniquely qualified to become entrepreneurs; they combine grit with the curiosity, depth of knowledge, and technical creativity necessary to turn world-changing ideas into sustainable venture...
13.11.2019EVENT December 3rd: AI and Digital Health - Where Are We Now? - (Civilization Ventures on Panel)EVENT - Hosted by Wilson Sonsini Goodrich & Rosati, featuring Amanda Cashin (Illumina Accelerator), Alex Morgan (Khosla Ventures), Shahram Seyedin-Noor (Civilization Ventures), Adam D'Augelli (True Ventures), and Amit Garg (Tau Venture...
14.10.2019ABBOTT AND OMADA HEALTH PARTNER TO OFFER INTEGRATED DIGITAL HEALTH AND COACHING EXPERIENCE FOR PEOPLE WITH TYPE 2 DIABETESFrom PRNewswire – Read original article
10.10.2019PRESS RELEASE: Intermountain Ventures Invests in Omada HealthPress Release – Read original article
04.10.2019Civilization Ventures GP, Shahram Seyedin-Noor, Featured Panelist for Synbiobeta Discussion on Science and TechnologySynbiobeta 2019 – Civilization Ventures GP, Shahram Seyedin-Noor, Featured Panelist for Synbiobeta Discussion on Science and Technology On the main stage at Synbiobeta this year, a panel discussion focused on communicating biotech advance...
22.06.2019Civilization Ventures Announces Portfolio Exit with Acquisition of Singular Bio by Invitae (NYSE: NVTA)From Business Wire – RELATED LINKS https://www.civilizationventures.com/ https://www.singularbio.com/ https://www.invitae.com/ Read original article
28.03.2019Prenatal Testing Firm BillionToOne Closes $15M Series A FinancingFrom Genome Web – Read original article
28.03.2019Prellis Biologics raises $9mFrom Mass Device – Read original article
18.03.2019Wild Earth Reels in $550,000 from Mark Cuban in 'Shark Tank'From PR Newswire – BERKELEY, Calif., March 18, 2019 /PRNewswire/ -- Wild Earth, Inc., a startup reinventing pet food with biotech, today announced it has accepted an investment of $550,000 from serial entrepreneur, investor, and owner of t...
24.01.2019Will This New Robot That Helps You Take Pills Have a Better Fate Than Jibo?From BostInno: Will This New Robot That Helps You Take Pills Have a Better Fate Than Jibo? www.pillohealth.com Read original article
Show more

Mentions in press and media 16

DateTitleDescription
15.12.2025ial Library Secures $10M to Democratize Clinical Trial AccessTrial Library, a San Francisco-based AI platform, just raised $10 million in Series A funding. This investment aims to expand access to clinical trials *outside* major research hospitals. The company focuses on community-based care. It uses...
10.12.2025Trial Library: $10 Million Raised To Expand Access To Community-Based Clinical TrialsTrial Library has secured $10 million in Series A funding to accelerate its efforts to expand access to clinical trials within community healthcare settings. The round was co-led by Next Ventures and SemperVirens Venture Capital, with parti...
31.10.2025Curve Biosciences Ignites New Era in Chronic Disease Care with $40M FundingCurve Biosciences recently secured $40M in Series A funding. This capital fuels its Whole-Body Intelligence platform. The platform uses the proprietary Whole-Body Atlas, a vast collection of tissue samples. It powers advanced Whole-Body Blo...
30.10.2025Curve Biosciences: $40 Million Raised To Advance Whole-Body Intelligence Platform for Chronic Disease MonitoringCurve Biosciences, a biotechnology company pioneering Whole-Body Intelligence for proactive and personalized chronic disease care, has raised $40 million in new funding led by Luma Group, with participation from First Spark Ventures, Techas...
29.10.2025Curve Biosciences Secures $40M to Launch Whole-Body Intelligence PlatformWhat You Should Know: – Curve Biosciences, the Whole-Body Intelligence™ company, today announced it has raised $40M in Series A funding led by Luma Group, with participation from First Spark Ventures, Techas Capital, Civilization Ventures, ...
11.08.2025Tahoe Therapeutics Raises $30M in New FundingTahoe Therapeutics, a San Francisco, CA-based AI-powered models provider for the human cell, raised $30M in new funding. The round was led by Amplify Partners, with participation from Databricks Ventures, Wing Venture Capital, General Catal...
08.06.2025Antheia's $56 Million Boost: A Game Changer in Pharmaceutical ManufacturingAntheia, a Menlo Park-based pharmaceutical ingredient manufacturer, has struck gold with its recent $56 million Series C funding round. This infusion of capital, led by the Global Health Investment Corporation (GHIC), marks a significant le...
07.06.2025Antheia: $56 Million Series C Raised For Advancing Global Commercialization StrategyAntheia, a pharmaceutical ingredient manufacturer transforming essential medicine supply chains, announced it has raised $56 million in Series C financing. The Series C funding round was led by Global Health Investment Corporation (GHIC), a...
06.05.2025Dawn Health secures $13M for global expansionPhoto: martin barraud/Getty Images Copenhagen-based digital health company specializing in chronic disease management Dawn Health secured $13 million (€11.5 million) from existing investors Chr. Augustinus Fabrikker, the export and investme...
28.06.2024BillionToOne: Molecular Diagnostics Company Raises $130 MillionBillionToOne, a next-generation molecular diagnostics company, announced that it has raised $130 million in an oversubscribed and upsized Series D round. This funding was led by Premji Invest, with significant participation by another incom...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In